Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer

fiercepharmaNovember 08, 2017

Tag: Roche , Pfizer , Novartis

PharmaSources Customer Service